GATE BT 2020 • Q19 MCQ • 1 Mark

Section 4: Bioprocess Engineering and Process Biotechnology

Mass transfer in bioprocesses (kLa)

Subtopic: Fundamentals of Mass transfer in bioprocesses (kLa)

Question Statement:

During a positive-negative selection process, transformed animal cells expressing are killed in presence of ganciclovir in the medium.

Options:

  • (A) pyruvate kinase
  • (B) viral thymidine kinase
  • (C) viral serine/threonine kinase
  • (D) viral tyrosine kinase

Official Answer Key:

B

Step-by-Step Solution & Explanation

### **Official Solution & Concept Analysis (GATE BT 2020 Q.19)** **1. Governing Concept**: - **Topic**: Genetic Engineering & Gene Targeting (Positive-Negative Selection) - In gene targeting in embryonic stem cells (Mansour et al.): - **Positive selection marker**: Neomycin phosphotransferase ($neo^r$), inserted into the target exon, confers resistance to G418 (selects for vector integration). - **Negative selection marker**: Herpes simplex virus thymidine kinase (*HSV-tk*), placed at the flank of the targeting construct. - If random (non-homologous) integration occurs, *HSV-tk* is retained, and its expression converts the non-toxic nucleoside analog **ganciclovir** into a toxic phosphorylated compound that kills the cells. - Thus, cells expressing **viral thymidine kinase** are killed in the presence of ganciclovir. **2. Option Analysis**: - **Option (A) is INCORRECT**: Pyruvate kinase is a normal glycolytic enzyme. - **Option (B) [viral thymidine kinase] is CORRECT**: Phosphorylates ganciclovir into a cytotoxic chain-terminator. - **Option (C) is INCORRECT**: Non-existent selection enzyme. - **Option (D) is INCORRECT**: Tyrosine kinases do not metabolize ganciclovir. **3. Final Answer**: - **Correct Choice**: **B**

Practice This in Real CBT Exam Interface

Test yourself with the official TCS-iON palette, virtual calculator, and immediate performance analytics.

Launch CBT Mock Test